Whitehawk Therapeutics Inc

WHWKNASDAQHealthcare● Active

$4.02

$-0.13(-3.13%)

Market Cap$198798901

P/E Ratio—

52W High$5.495

52W Low$1.57

Avg Volume305K

Open$4.15

Beta0.77

Revenue Financials Earnings

Whitehawk Therapeutics Inc (WHWK) Revenue

Annual & quarterly revenue history · segment & region breakdown

WHWK · revenue · updated Jun 9, 2026

Core revenue metrics

Trailing 12 months

Whitehawk Therapeutics Inc trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue

$0.00B

4-quarter sum · USD

YoY growth

+0.00%

vs FY —

Price / sales

—

mktCap ÷ TTM rev

Revenue per day

—

Est. TTM ÷ 365

Revenue / employee

$0K

40 employees

—

5Y CAGR

—

Fiscal year end

Dec 31

Currency

USD · GAAP

Filing

10-K / 10-Q

Source: FMP · Whitehawk Therapeutics Inc SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

– · Annual

YoY revenue growth %

revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year end	Revenue	Change	Growth

WHWK revenue by year · WHWK revenue history · WHWK annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Whitehawk Therapeutics Inc receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Whitehawk Therapeutics Inc reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Whitehawk Therapeutics Inc's 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Price history Financial statements Forecast

Frequently asked questions

WHWK revenue · 4 questions

WHWK's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

WHWK revenueWHWK annual revenuewhat is WHWK revenueWHWK TTM revenue

▸ Source: FMP · Whitehawk Therapeutics Inc SEC filings · GAAP · Whitehawk Therapeutics Inc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026